However, a new UBCO study published in Nature’s Scientific Reports in August shows that THC and CBD are much less important factors than previously thought.

Dr. Susan Murch’s lab studies the biochemistry of plants that affect human health, discovering new chemicals in the process. PhD candidate Elizabeth Murch worked with the British Columbia Institute of Technology’s (BCIT) Dr. Paula Brown to compare the CBD and THC levels in 33 different cannabis strains.

They found that despite all the exotic names, 24 of those strains were too similar in CBD and THC makeup to warrant their differently-advertised effects. However, the study did detect previously-unknown compounds that differ between the strains and are potentially related to both the differences in pharmacological and perceived effects.

“Just knowing THC and CBD is not enough, we need to know more about the other molecules that are there,” said Murch.

The study took place both at UBC and BCIT, in part because BCIT is licensed to work with cannabis while UBC is not.

“I never thought I would work on cannabis,” Murch said. “There’s an amazing potential here to discover new chemicals that can be useful medicine — useful treatment for various ailments, especially things like pain management and other chronic conditions.”

“The strains are all coming from a very narrow gene pool,” she said. “They originated from people who were growing cannabis, probably illegally, who just picked a variant that seemed different somehow.”

Now that cannabis is legal, the improved ease of studying the substance may allow scientists to breed varieties for specific health outcomes, improving Canadian consumers’ understanding of the substances that they consume